Hasmukh Rawal, Managing Director, Mylab Discovery Solutions, Pune
What are the key advantages being offered by the Compact XL system compared to the conventional RT-PCR testing systems?
Compact XL is a sample-to-PCR ready machine for molecular diagnostics that eliminates the huge infrastructure cost of setting up a molecular lab. It is designed to automate lab operations from sample handing to RT-PCR tube preparation. It has flexibility to test multiple parameters with multiple samples at the same time, a never before the feature. With 32 separate channels, dual-deck facility, automated barcode reading, auto fed protocol, self-sanitization, and laboratory information management system (LIMS) connectivity defines Compact XL, as a complete walk-away system. It is a cartridge-based machine and can test multiple samples concurrently. It can be used for a wide range of RNA/DNA-based tests including COVID-19 RT-PCR tests. The machine can take a variety of sample types such as plasma, tissue, sputum, and swab. Other benefits include: Save on real estate costs- no need for multiple rooms and 1000+ sq ft of space. Compact XL reduces footprint to a single room of 100 sqft; Reduced manpower- a traditional lab needs 3-4 skilled molecular biologists. Compact XL allows you to run a lab with just 1 technician; Less Equipment & Consumables- significantly cost-saving on dozens of small equipment and consumables, made obsolete by Compact XL; Zero Manual Error- an automated process with no manual intervention. Accurate material handling and process adherence for reliable results; Low maintenance- Compact XL is a hassle and maintenance free system to save you costs in short and long term. To make India self-reliant in advanced diagnostics, Compact XL is our most ambitious project to date.
This story is from the September 2020 edition of Bio Spectrum.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.
Already a subscriber ? Sign In
This story is from the September 2020 edition of Bio Spectrum.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.
Already a subscriber? Sign In
Sartorius Stedim Biotech opens new centre for bioprocess innovation in US
Sartorius Stedim Biotech, a leading partner of the biopharmaceutical industry, has opened its new centre for Bioprocess Innovation in Marlborough, Massachusetts in the US.
Agilent introduces innovative Mito-rOCR assay kit for mitochondrial research
Agilent Technologies Inc. has announced the new MitorOCR Assay Kit.
Qiagen launches AI-extension of Ingenuity Pathway Analysis for automatic interpretation of biological data
Qiagen has announced the launch of Ingenuity Pathway Analysis (IPA) Interpret, a new feature designed to simplify and accelerate the interpretation of complex biological data.
Parse Biosciences announces expansion of Evercode BCR product line
Parse Biosciences, a leader in scalable single cell sequencing solutions, has announced the expansion of its Evercode BCR product line to enable applications in mice.
New technology for unambiguous detection of HIV genome using tailored fluorogenic tests
A team of scientists at Jawaharlal Nehru Centre for Advanced Scientific Research (JNCASR), has developed a novel diagnostic technology known as the GQ Topology-Targeted Reliable Conformational Polymorphism (GQ-RCP) platform.
Gene mutation likely cause for developing autism in early childhood: RGCB study
Autism, a developmental disorder that causes functional abnormalities in brain development, is caused by a combination of environmental and genetic factors with its symptoms manifesting in childhood as early as the age of two years.
IIIT-Delhi unveils AI platform for discovering molecules that promote healthy ageing
A team of researchers from Indraprastha Institute of Information Technology Delhi (IIIT-Delhi) has developed AgeXtend, a groundbreaking artificial intelligence (AI)-based platform that is set to transform the search for molecules promoting healthy ageing.
RSSDI study lays focus on Yoga and Diabetes Prevention
Dr Jitendra Singh, Union Minister of State (Independent Charge) for Science and Technology, recently released the landmark study by Research Society for Study of Diabetes in India (RSSDI) on 'Yoga and Diabetes Prevention'.
Dr Alok Khullar steps in as Group CEO of RJ Corp Healthcare
RJ Corp Healthcare, a leading name in the healthcare sector through its renowned entities Cocoon Hospital and Cryoviva Stem Cell Bank, has announced the appointment of Dr Alok Khullar as Group Chief Executive Officer (CEO).
Entod Pharmaceuticals on-boards Dr Anish Desai as Scientific & Research adviser
Mumbai-based Entod Pharmaceuticals has appointed Dr Anish Desai as its Scientific and Research Adviser.